Solid Biosciences Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-37.9M | $7.7M |
| FY2017 | — | $-59.3M | $52.1M |
| FY2018 | — | $125.2M | $86.4M |
| FY2019 | — | $80.0M | $76.0M |
| FY2020 | — | $132.1M | $154.7M |
| FY2021 | — | $208.2M | $119.1M |
| FY2022 | — | $211.7M | $155.4M |
| FY2023 | — | $126.5M | $74.0M |
| FY2024 | — | $137.2M | $80.2M |
| FY2025 | — | $180.0M | $59.9M |